3-nitropropionic acid has been researched along with Cognition Disorders in 7 studies
3-nitropropionic acid: succinate dehydrogenase inactivator; biosynthesized by FABACEAE plants from ASPARAGINE
3-nitropropanoic acid : A C-nitro compound that is propanoic acid in which one of the methyl hydrogens has been replaced by a nitro group.
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ellagic acid (EA) is a naturally derived polyphenol acknowledged for potent neuroprotective abilities that enabled its significance amongst popular brain tonics." | 1.62 | Ellagic acid prevents 3-nitropropionic acid induced symptoms of Huntington's disease. ( Bansal, N; Kumar, M; Sharma, P, 2021) |
| "Sesamol pre-treatment restored oxidative defence possibly by its free radical scavenging activity as compared to the 3NP-treated group." | 1.36 | Protective effect of sesamol against 3-nitropropionic acid-induced cognitive dysfunction and altered glutathione redox balance in rats. ( Kalonia, H; Kumar, A; Kumar, P, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Sharma, P | 1 |
| Kumar, M | 1 |
| Bansal, N | 1 |
| Mehrotra, A | 1 |
| Kanwal, A | 1 |
| Banerjee, SK | 1 |
| Sandhir, R | 1 |
| Kumar, P | 4 |
| Kumar, A | 4 |
| Kalonia, H | 2 |
| Shear, DA | 1 |
| Haik, KL | 1 |
| Dunbar, GL | 1 |
7 other studies available for 3-nitropropionic acid and Cognition Disorders
| Article | Year |
|---|---|
Ellagic acid prevents 3-nitropropionic acid induced symptoms of Huntington's disease.
Topics: Animals; Catalase; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; El | 2021 |
Mitochondrial modulators in experimental Huntington's disease: reversal of mitochondrial dysfunctions and cognitive deficits.
Topics: Acetylcarnitine; Animals; Cognition Disorders; Drug Therapy, Combination; Female; Huntington Disease | 2015 |
Neuroprotective effect of cyclosporine and FK506 against 3-nitropropionic acid induced cognitive dysfunction and glutathione redox in rat: possible role of nitric oxide.
Topics: Acetylcholinesterase; Analysis of Variance; Animals; Arginine; Behavior, Animal; Brain; Cognition Di | 2009 |
Protective role of sertraline against 3-nitropropionic acid-induced cognitive dysfunction and redox ratio in striatum, cortex and hippocampus of rat brain.
Topics: Acetylcholinesterase; Animals; Antidepressive Agents; Antihypertensive Agents; Behavior, Animal; Bra | 2009 |
Protective effect of sesamol against 3-nitropropionic acid-induced cognitive dysfunction and altered glutathione redox balance in rats.
Topics: Animals; Behavior, Animal; Benzodioxoles; Cognition Disorders; Disease Models, Animal; Escape Reacti | 2010 |
Nitric oxide mechanism in the protective effect of antidepressants against 3-nitropropionic acid-induced cognitive deficit, glutathione and mitochondrial alterations in animal model of Huntington's disease.
Topics: Animals; Antidepressive Agents; Cognition Disorders; Convulsants; Disease Models, Animal; Dose-Respo | 2010 |
Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats.
Topics: Animals; Behavior, Animal; Cerebral Ventricles; Cognition Disorders; Corpus Striatum; Creatine; Male | 2000 |